Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts

Cancer Research

Volumn 69, Issue 9, 2009, Pages 3746-3754

  Cedervall, Jessica ^a   Jamil, Seema ^a   Prasmickaite, Lina ^b   Cheng, Yenfu ^a   Eskandarpour, Malihe ^a   Hansson, Johan ^a   Mælandsmo, Gunhild M ^b   Ringborg, Ulrik ^a   Gulyas, Miklos ^d   Zhen, He Suo ^c   Kanter, Lena ^a   Ahrlund Richter, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF CANCER RESEARCH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Central Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL DEDIFFERENTIATION; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENGRAFTMENT; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MELANOMA CELL; MESENCHYME; MICROENVIRONMENT; MOUSE; NEURAL CREST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPECIES DIFFERENCE; TERATOMA; XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; EMBRYONAL CARCINOMA STEM CELLS; EMBRYONIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PHENOTYPE; S100 PROTEINS; SPECIES SPECIFICITY; TERATOMA; TRANSPLANTATION, HETEROLOGOUS;

EID: 65949095231     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3746     Document Type: Article

References (43)

1. Levenberg S, Huang NF, LavikE, Rogers AB, Itskovitz- Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. PNAS 2003;100:12741-6.
2. Smalley KS, Lioni M, Noma K, Haass NK, Herlyn M. In vitro three-dimentional tumor microenvironment models for anticancer drug discovery. Expert Opin Drug Discov 2008;3:1-20.
3. Seftor EA, Meltzer PS, Kirschmann DA, Margaryan NV, Seftor RE, Hendrix MJ. The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment. J Cell Mol Med 2006;10:174-96.
4. Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. PNAS 2004;101:4966-71.
5. Chen J, Blackwell TW, Fermin D, et al. Evolutionaryconserved gene expression response profiles across mammalian tissues. OMICS 2007;11:96-115.
6. Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R, Skorecki K. An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. PNAS 2003;100:13507-12.
7. Tzukerman M, Rosenberg T, Reiter I, et al. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 2006;66:3792-81.
8. Hovatta O, Mikkola M, Gertow K, et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 2003;18:1404-9.
9. Inzunza J, Gertow K, Strömberg AM, et al. Derivation of human embryonic stem cell lines in serum-free medium using postnatal human fibroblasts as feeder cells. Stem Cells 2005;23:544-9.
10. Gertow K, Przyborski S, Loring J, et al. Isolation of HESC-derived teratomas for the assessment of pluripotency. In:Current Protocols in Stem Cell Biology. Chapt 1B:4, 2007. p. 1-24.
11. Gertow K, WolbankS, Rozell B, et al. Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev 2004;13:421-5.
12. Damjanov I, Ährlund-Richter L. Characterization of hESC-derived teratomas. In Human Stem Cell Manual:A Laboratory Guide, by Loring JF, Schwartz PH, and Wesselschmidt R. Elsevier Press. 2007.
13. Gertow K, Cedervall J, Unger C, et al. Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J Cell Biochem 2007;100:1518-25.
14. Imreh M, Gertow K, Cedervall J, et al. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J Cell Biochem 2006;99:508-16.
15. Gerecht-Nir S, Osenberg S, Nevo O, Ziskind A, Coleman R, Itskovitz-Eldor J. Vascular development in early human embryos and in teratomas derived from human embryonic stem cells. Biol Reprod 2004;71:2029-36.
16. Salazar-Onfray F, Nakazawa T, Chhajlani V, et al. Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2- restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells. Cancer Res 1997;57:4348-55.
17. Salazar-Onfray F, Lopez M, Lundqvist A, et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer 2002;87:414-22.
18. Topczewska JM, Postovit LM, Margaryan NV, et al. Embryonic and tumorigenic pathways converge via Nodal signaling:role in melanoma aggressiveness. Nat Med 2006;12:925-32.
19. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004;51:1-28.
20. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumor-cell plasticity:lessons from melanoma. Nat Rev Cancer 2003;3:411-21.
21. Lee JT, Herlyn M. Microenvironmental influences in melanoma progression. J Cell Biochem 2007;101:862-72.
22. Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, et al. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. PNAS 2006;103:3752-7.
23. Hendrix MJ, Seftor RE, Seftor EA, et al. Transendothelial function of human metastatic melanoma cells:role of the microenvironment in cell-fate determination. Cancer Res 2002;62:665-8.
24. Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. Dev Dyn 2005;233:1560-70.
25. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
26. Imreh MP, Wolban kS, Unger C, et al. Culture and expansion of the human embryonic stem cell line HS181, evaluated in a double color system. Stem Cells Dev 2004;13:337-43.
27. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry. Am J Pathol 1999;155:739-52.
28. Maniotis AJ, Chen X, Garcia C, et al. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest 2002;82:1031-43.
29. Ruf W, Seftor EA, Petrovan RJ, et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res 2003;63:5381-9.
30. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem 2006;281:677-80.
31. Flatmar kK, Maelandsmo GM, Mikalsen SO, et al. Immunofluorometric assay for the metastasis-related protein S100A4:release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum. Tumour Biol 2004;25:31-40.
32. Brychtova S, Fiuraskova M, Hlobilkova' A, Brychta T, Hirnak J. Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol 2007;34:370-5.
33. Ehrmann J, Kolár Z, Mokry J. Nestin as a diagnostic and prognostic marker:immunohistochemical analysis of its expression in different tumors. J Clin Pathol 2005;58:222-3.
34. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-51.
35. Mueller A, Schäfer BW, Ferrari S. The calciumbinding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 2005;280:29186-93.
36. Kriajevska M, Fischer-Larsen M, Moertz E, et al. Liprin β1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem 2003;277:5229-35.
37. Postovit LM, Margaryan NV, Seftor EA, et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. PNAS 2008;105:4329-34.
38. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. PNAS 2002;99:9864-9.
39. Chen YT, Dejosez M, Zwaka TP, Behringer RR. H1and H9 human embryonic stem cell lines are heterozygous for the ABO locus. Stem Cells Dev. Epub ahead of print 2008 Jun. 18.
40. Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002;2:859-71.
41. Mosier DE, Stell KL, Gulizia RJ, Torbett BE, Gilmore GL. Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cellinduced B cell generation. J Exp Med 1993;177:191-4.
42. Eskandarpour M, Kiaii S, Zhu C, Castro J, Sakko AJ, Hansson J. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells. Int J Cancer 2005;115:65-73.
43. Eskandarpour M, Huang F, Reeves KA, Clark E, Hansson J. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer 2009;124:16-26.